RC Capital
VC Fund
Cincinnati, United States
RC Capital is a VC fund in Cincinnati focused on Health Care and Software. RCC is a growth equity firm building high-potential healthcare companies by leveraging the unique interplay of our segments of focus: medical device, healthcare services and healthcare IT. We are dedicated to investing on the right side of healthcare, growing companies that enable clinicians to improve the delivery of care and the experiences andoutcomes for patients. We seek to be a business partner first and a capital provider second, investing significant human capital to leverage our domain expertise, a network of healthcare thought leaders and deep relationships with health systems assembled over our 28-year history. With more than $900 million of capital raised and a consistent track record, the firm has established itself as a preferred source of growth capital.
- Total investments:
- 118
- Last investment:
- Lead investor:
- 47%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries RC Capital invests in
Stages RC Capital invests in
Countries RC Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Investment Focus
Industry
- Health Care 36 (31%)
- Software 24 (20%)
- Medical 21 (18%)
- Medical Device 16 (14%)
- SaaS 12 (10%)
Stage
- Funding Round 27 (23%)
- Series B 22 (19%)
- Series C 21 (18%)
- Series A 11 (9%)
- Series D 11 (9%)
Country
- United States 80 (68%)
- Japan 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adam Midkiff
Principal
|
Principal | Total investments: 1 | Find email | |
| CFO | Total investments: 0 | Find email | ||
Britney Hamberg
Vice President Marketing; Director of Operations and Communications
|
Vice President Marketing; Director of Operations and Communications | Total investments: 0 | Find email | |
Carter McNabb
Managing Director
|
Managing Director | Total investments: 20 | Find email | |
Daniel T. Fleming
Managing Director
|
Managing Director | Total investments: 5 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Captive Radiology
|
Captive Radiology offers its services to hospitals and physician groups. They are laser-focused on maximizing the clinical, market, and financial potential of diagnostic imaging services. Their services include analysis, operations management, project management, radiology staffing, radiology equipment, accreditation, healthcare marketing, qualityassurance, and more. | Private Equity / May 22, 2026 | |
|
Captive Radiology
|
Captive Radiology offers its services to hospitals and physician groups. They are laser-focused on maximizing the clinical, market, and financial potential of diagnostic imaging services. Their services include analysis, operations management, project management, radiology staffing, radiology equipment, accreditation, healthcare marketing, qualityassurance, and more. | Private Equity / May 22, 2026 | |
ModifyHealth
|
ModifyHealth is a digital health platform that aims to improve outcomes and reduce costs for those with chronic conditions such as diabetes, heart disease, and kidney disease. The company also provides a meal delivery service that provides fully-prepared, nutritious meals designed to support those with chronic health conditions. They offergluten-free and low-FODMAP options to help manage symptoms. | $13.5M / Series C / Dec 04, 2024 | |
Catalyst OrthoScience
|
Catalyst OrthoScience is an early stage medical device company that is bringing the Catalyst CSR total shoulder to market. The CSR total shoulder is an innovative, streamlined solution that is associated with less stretching of the muscles and ligaments in order to place the implants. It is designed to be a more natural solution with a focus onrapid recovery for the patient. | $20M / Venture - Series Unknown / Sep 10, 2024 | |
Spineology
|
Spineology provides anatomy-conserving spine surgery technology solutions. It offers pedicular fixation products, such as Palisade, threshold, and fortress pedicular fixation; Biologics products, such as Essence viable amnion matrix, Blockade amniotic protective barrier, Incite DBM strips, and Incite cortical fibers; and Interbody products, such asthe Duo systems, Elite expandable, Rampart one, and Rampart T interbody fusion products. Spineology also offers capture facet fixation, VIA spinous process fixation, Medius retractor system, SOAR retractor system, ProMap EMG nagivation systems, and OptiMesh graft containment. Stephan Kuslich founded it in 1996, with its headquarters in St. Paul in Minnesota. | $25M / Series A / Aug 06, 2024 | |
Elucent Medical
|
Elucent Medical is a new idea in breast cancer treatment that exists to bring better healthcare ideas to light through the collective efforts of proven entrepreneurs in medicine, technology, and business. Its aim is to raise the bar for breast cancer treatment while lowering costs, making procedures accessible and affordable for providers andpatients alike.Elucent Medical is based in Madison, W.I. | $42.5M / Series C / Apr 10, 2024 | |
Avive Solutions
|
Avive Solutions develops a next-generation Automated External Defibrillator (AED) and software solutions. Avive's AED enables anyone to positively impact the outcome of a Sudden Cardiac Arrest (SCA) rescue by building a more robust solution that addresses the problem of SCA in its entirety. The AED will remove barriers to respond to a SCAscenario. It will be easy to purchase, easy to access in an emergency, easy to keep maintained, and most importantly easy to use effectively when it matters most.Avive Solutions is headquartered in San Francisco, California. | $56.5M / Series B / Feb 14, 2024 | |
SPR Therapeutics
|
SPRA Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. They are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product tobe commercialized is the SMARTPATCHâ„¢ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain. | $25M / Series D / Feb 01, 2024 | |
James River Cardiology
|
James River Cardiology provides coronary artery disease, arterial disease, heart failure, valvular heart disease, TAVR, peripheral vascular disease, venous disease, arrhythmia management, and preventive cardiology. Their customers' enquiries are addressed through phone, email, and online application. | Private Equity / Jun 14, 2023 | |
|
James River Cardiology
|
James River Cardiology provides coronary artery disease, arterial disease, heart failure, valvular heart disease, TAVR, peripheral vascular disease, venous disease, arrhythmia management, and preventive cardiology. Their customers' enquiries are addressed through phone, email, and online application. | Private Equity / Jun 14, 2023 | |
| See all 118 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does RC Capital invest in?
RC Capital invests primarily in Health Care, Software and Medical startups, most often at Funding Round and Series B stage. Most of the 118 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact RC Capital?
Public channels for RC Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at RC Capital?
The team at RC Capital includes Adam Midkiff (Principal), Adrienne Vannarsdall (CFO) and Britney Hamberg (Vice President Marketing; Director of Operations and Communications), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
